We are live on
!
Find out more
CCMU
Cheyne Capital Management (UK) Portfolio holdings
AUM
$27.9M
1-Year Est. Return
36.14%
This Fund
S&P 500
This Quarter
Est. Return
-1.06%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$185M
AUM Growth
-$28.4M
(-13%)
Cap. Flow
-$25M
Cap. Flow
% of AUM
-13.51%
Top 10 Holdings %
Top 10 Hldgs %
90.02%
Holding
50
New
9
Increased
2
Reduced
5
Closed
17
Top Buys
| 1 |
ATML
ATMEL CORP
ATML
|
+$31.3M |
| 2 |
LivaNova
LIVN
|
+$27.6M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$24.9M |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$11.1M |
| 5 |
CVC
CABLEVISION SYS CP NY GRP CL-A
CVC
|
+$6.37M |
Top Sells
| 1 |
Sunoco
SUN
|
+$36.1M |
| 2 |
CYT
CYTEC INDS INC
CYT
|
+$36.1M |
| 3 |
BEE
STRATEGIC HOTELS & RESORTS, INC
BEE
|
+$24.5M |
| 4 |
ALTR
Altera Corp
ALTR
|
+$15M |
| 5 |
HME
HOME PROPERTIES, INC
HME
|
+$14.1M |
Sector Composition
| 1 | Communication Services | 16.92% |
| 2 | Healthcare | 16.5% |
| 3 | Industrials | 15.65% |
| 4 | Technology | 13.88% |
| 5 | Energy | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATML
1
DELISTED
ATMEL CORP
ATML
| $32.2M | 17.42% |
+3,735,309
| New | +$31.3M |
|
|
CVC
2
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $30.2M | 16.36% |
947,731
+201,182
| +27% | +$6.37M |
|
|
PCP
3
DELISTED
PRECISION CASTPARTS CORP
PCP
| $28.9M | 15.65% |
124,635
+48,135
| +63% | +$11.1M |
|
|
4
LivaNova
LIVN
$4.43B
| $27M | 14.63% |
+455,214
| New | +$27.6M |
|
|
EMC
5
DELISTED
EMC CORPORATION
EMC
| $24.6M | 13.32% |
+958,731
| New | +$24.9M |
|
6
Kinder Morgan
KMI
$71.9B
| $2.76M | 1.49% |
+185,000
| New | +$4.41M |
|
7
RadNet
RDNT
$4.89B
| $1.44M | 0.78% |
232,809
-47,191
| -17% | -$292K |
|
|
WLL
8
DELISTED
Whiting Petroleum Corporation
WLL
| $1.24M | 0.67% |
+437
| New | +$2.07M |
|
9
Walt Disney
DIS
$170B
| $1.05M | 0.57% |
+10,000
| New | +$1.11M |
|
10
PTC
PTC
$14.4B
| $1.04M | 0.56% |
+30,000
| New | +$1.05M |
|
|
INFI
11
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $778K | 0.42% |
99,000
-121,618
| -55% | -$1.05M |
|
|
OREX
12
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $709K | 0.38% |
41,320
-80,219
| -66% | -$1.91M |
|
|
COOP
13
DELISTED
Mr. Cooper
COOP
| $567K | 0.31% |
18,333
| – | – |
|
|
ADMS
14
DELISTED
Adamas Pharmaceuticals
ADMS
| $418K | 0.23% |
14,765
-15,235
| -51% | -$256K |
|
15
Kinross Gold
KGC
$27B
| $390K | 0.21% |
215,000
| – | – |
|
|
B
16
Barrick Mining
B
$58.5B
| $369K | 0.2% |
50,000
| – | – |
|
17
Vanda Pharmaceuticals
VNDA
$327M
| $363K | 0.2% |
39,000
-70,000
| -64% | -$699K |
|
|
ALIM
18
DELISTED
Alimera Sciences
ALIM
| $177K | 0.1% |
4,867
| – | – |
|
|
KMI.WS
19
DELISTED
Kinder Morgan Inc
KMI.WS
| – | – |
0
| – | – |
|
20
Achieve Life Sciences
ACHV
$644M
| – | – |
-28
| Closed | -$137K |
|
21
Aurinia Pharmaceuticals
AUPH
$2.05B
| – | – |
-90,000
| Closed | -$257K |
|
22
Criteo
CRTO
$1.13B
| – | – |
-18,599
| Closed | -$698K |
|
23
Edgewell Personal Care
EPC
$1.37B
| – | – |
-10,000
| Closed | -$816K |
|
24
Inovio Pharmaceuticals
INO
$92.1M
| – | – |
-5,833
| Closed | -$404K |
|
25
Mastercard
MA
$480B
| – | – |
-12,000
| Closed | -$1.08M |
|
Similar funds
VAFP
HSCU
TCM
ECM
AMC
P
AOGP
CA
Cheyne Capital Management (UK)'s Q4 2015 Portfolio in Review
As of Q4 2015, Cheyne Capital Management (UK) held 50 positions worth $185M, down 13% from $213M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Cheyne Capital Management (UK) withdrew a net $25M in Q4 2015, closing 17 positions and reducing 5 holdings. Its most notable exit was Sunoco, an estimated $36.1M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 17% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Cheyne Capital Management (UK) opened a new position in ATMEL CORP worth $32.2M.
- Cheyne Capital Management (UK)'s largest Q4 2015 buy was ATMEL CORP: 3,735,309 shares worth $32.2M.
- Cheyne Capital Management (UK) added most to PRECISION CASTPARTS CORP in Q4 2015, an estimated $11.1M increase.
- Cheyne Capital Management (UK)'s biggest Q4 2015 reduction was Orexigen Therapeutics, Inc., cutting an estimated $1.91M.
- Cheyne Capital Management (UK) fully exited Sunoco in Q4 2015, selling an estimated $36.1M.
- Cheyne Capital Management (UK)'s ten largest holdings make up 90% of its $185M portfolio in Q4 2015.
- Cheyne Capital Management (UK) opened 9 new positions and closed 17 in Q4 2015.
- Cheyne Capital Management (UK)'s portfolio value fell 13% quarter-over-quarter to $185M.
Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2015, filed 15 Jan 2016.